Summary:
The purpose of this study is to evaluate the efficacy of a Respiratory Syncytial Virus vaccine. RSV is a common respiratory virus that usually causes mild, cold-like symptoms.
Qualified Participants Must:
• Be 60 years old and over
•
Healthy individuals, preexisting stable conditions may be okay
•
Be available to attend 4 visits and 3 phone calls
Qualified Participants May Receive:
- All study related care at no cost to you
- Compensation between $660-$1450